Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1635-1639

  Culpitt, Sarah V ^b   Maziak, Wasim ^b   Loukidis, Stelios ^b   Nightingale, Julia A ^b   Matthews, John L ^b   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; CYTOKINE; ELASTASE; FLUTICASONE PROPIONATE; GELATINASE B; INTERLEUKIN 8; IPRATROPIUM BROMIDE; SALBUTAMOL; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; STEROID; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM;

EID: 0032696013     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9811058     Document Type: Article

References (35)

1. Fletcher, C., R. Peto, C. Tinker, and F. E. Speizer. 1976. The Natural History of Chronic Bronchitis and Emphysema: An Eight Year Study of Early COPD in Working Men in London. Oxford University Press, Oxford.
2. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 51:267-271.
3. Tetley, T. D. 1993. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax 48:560-565.
4. Stockley, R. A. 1994. The role of protcinascs in the pathogenesis of chronic bronchitis. Am. J. Respir. Crit. Care Med. 150:S109-S113.
5. Repine, J. E., A. Bast, I. Lankhorst, and The Oxidative Stress Study Group. 1997. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156:341-357.
6. Keatings, V. M., P. D. Collins, D. M. Scott, and P. J. Barnes. 1996. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153:530-534.
7. Ronchi, M. C., C. Piragino, E. Rosi, M. Amendola, R. Duranti, and G. Scano. 1996. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 51:1000-1004.
8. Keatings, V. M., and P. J. Barnes. 1997. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am. J. Respir. Crit. Care Med. 155:449-453.
9. Laurell, C. B., and S. Eriksson. 1963. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand. J. Clin. Invest. 15:132-140.
10. Gross, P., E. A. Pfitzer, A. Toker, M. A. Babyak, and M. Kaschak. 1965. Experimental emphysema: its production with papain in normal and silicotic rats. Arch. Environ. Health 11:50-58.
11. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
12. Janoff, A., L. Raju, and R. Dearing. 1983. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. Am. Rev. Respir. Dis. 127:540-544.
13. Willenbrock, F., and G. Murphy. 1994. Structure-function relationships in the tissue inhibitors of metalloprotcinascs. Am. J. Respir. Crit. Care Med. 150(Suppl.):S165-S170.
14. O'Connor, C. M., and M. X. Fitzgerald. 1994. Matrix metalloproteinases and lung disease. Thorax 49:602-609,
15. Muley, T., M. Wiebel, V. Schulz, and W. Ebert. 1994. Elastinolytic activity of alveolar macrophages in smoking-associated pulmonary emphysema. Clin. Invest. 72:269-276.
16. Hautamaki, R. D., D. K. Kobayashi, R. M. Senior, and S. D. Shapiro. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002-2004.
17. Finlay, G. A., L. R. O'Driscoll, K. J. Russell, E. M. D'Arcy, J. B. Masterson, M. X. FitzGerald, and C. M. O'Connor. 1997. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am. J. Respir. Crit. Care Med. 156:240-247.
18. Finlay, G. A., K. J. Russell, K. J. McMahon, E. M. D'Arcy, J. B. Masterson, M. X. Fitzgerald, and C. M. O'Connor. 1997. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52:502-506.
19. Bingle, L., and T. D. Tetley. 1996. Secretory leukoprotease inhibitor: partnering alpha-1-proteinase inhibitor to combat pulmonary inflammation. Thorax 51:1273-1274.
20. Wiggins, J., J. A. Elliott, R. D. Stevenson, and R. A. Stockley. 1982. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease. Thorax 37:652-656.
21. Stockley, R. A., H. M. Morrison, J. A. Kramps, J. H. Dijkman, and D. Burnett. 1986. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition and effect of corticosteroid treatment. Thorax 41:442-447.
22. Clark, S. D., D. K. Kobayashi, and H. G. Welgus. 1987. Regulation of the expression of tissue inhibitors of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J. Clin. Invest. 80:1280-1288.
23. Shapiro, S. D. 1994. Elastolytic metalloproteinases produced by human mononuclear phagocytes: potential roles in destructive lung disease. Am. J. Respir. Crit. Care Med. 150(Suppl.):S160-S164.
24. Lomas, D. A., M. Ip, A. Chamba, and R. A. Stockley. 1991. The effect of in vitro and in vivo dexamethasone on human neutrophil function. Agents Actions 33:279-285.
25. Llewellyn-Jones, C. G., S. L. Hill, and R. A. Stockley. 1994. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro. Thorax 49:207-212.
26. Llewellyn-Jones, C. G., T. A. Harris, and R. A. Stockley. 1996. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am. J. Respir. Crit. Care Med. 153:616-621.
27. Keatings, V. M., A. Jatakanon, Y. M. Worsdell, and P. J. Barnes. 1997. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155:542-548.
28. Pizzichini, E., M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 154:308-317.
29. Watson, A., T. K. Lim, H. Joyce, and N. B. Pride. 1992. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Chest 101:350-355.
30. Thompson, A. B., M. B. Mueller, A. J. Heires, T. L. Bohling, D. Daughton, S. W. Yancey, R. S. Sykes, and S. I. Rennard. 1992. Aerosolized beclomethasone in chronic bronchitis: improved pulmonary function and diminished airway inflammation. Am. Rev. Respir. Dis. 146:389-395.
31. Confalonieri, M., E. Mainardi, R. Della Porta, S. Bernorio, L. Gandola, B. Beghe, and A. Spanevello. 1998. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 53:583-585.
32. Paggiaro, P. L., R. Dahle, I. Bakran, L. Frith, K. Hollingworth, and J. Efthimiou. 1998. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease: International COPD Study Group. Lancet 351:773-780.
33. Richman, E. J., P. G. Jorens, C. A. Hebert, I. Ueki, and J. A. Nadel. 1993. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am. J. Physiol 264: L413-L418.
34. Shapiro, S. D., D. K. Kobayashi, A. P. Pentland, and H. G. Welgus. 1993. Induction of macrophage metalloproteinases by extracellular matrix. J. Biol. Chem. 268:8170-8175.
35. Shapiro, S. D., D. K. Kobayashi, and T. J. Ley. 1993. Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268:23824-23829.